Actemra 200 mg (Tocilizumab 200 mg / 10 ml) by Roche.
Indications: Rheumatoid arthritis, systemic and polyarticular juvenile idiopathic arthritis, giant cell arteritis, cytokine release syndrome and severe COVID-19 (per SmPC).
Administration: Intravenous infusion, typically 8 mg/kg every 4 weeks (RA).
Storage: Store in a refrigerator at 2–8 °C. Do not freeze. Keep in the outer carton to protect from light.
Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only.
| Manufacturer | Roche (Chugai) |
| Active ingredient | Tocilizumab 200 mg / 10 ml (20 mg/ml) — anti-IL-6 receptor monoclonal antibody (RoActemra in the EU). |
| Strength & pack | 1 vial. |
| Form | Concentrate for solution for infusion |
| Storage | Store in a refrigerator at 2–8 °C. Do not freeze. Keep in the outer carton to protect from light. |
| Regulatory status | Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only. |